Skip to main content
Clinical Trials/NL-OMON31670
NL-OMON31670
Recruiting
Phase 4

Three non-invasive Treatment Options for superficial basal cell carcinoma: PDT vs. imiquimod vs. 5-fluorouracil - Treatment of sBCC

Academisch Medisch Centrum0 sites600 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
basal cell carcinoma
Sponsor
Academisch Medisch Centrum
Enrollment
600
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • All patients with a primary (no previous treatment) histopathologically confirmed diagnosis of one or more sBCCs aged between 18 and 80 years old.

Exclusion Criteria

  • Patients using immunosuppressive drugs, patients with genetic skin cancer disorders, location in the H\-zone or the hairy head, earlier treatments at the same site and pregnancy.

Outcomes

Primary Outcomes

Not specified

Similar Trials